With $380 million in facility-specific investment and 300 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). It is also confirmed by official public sources and involves a physical manufacturing facility in the United States.
View full methodology →The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
At a glance
- Company
- AbbVie
- Industry
- Pharmaceuticals
- Location
- North Chicago, Illinois
- Investment
- $380.0M
- Permanent jobs announced
- 300
- Status
- Planning
- Announced
- Feb 23, 2026
- Expected opening
- 2029
- Added to tracker
- Sep 1, 2026
Official references
- AbbVie's February 23, 2026 North Chicago two-API-facility announcement https://news.abbvie.com/2026-02-23-AbbVie-to-Invest-380-Million-in-North-Chicago-to-Further-Expand-Active-Pharmaceutical-Ingredient-Manufacturing-in-the-United-States
- Illinois announcement of AbbVie's $380 million / 300-job North Chicago API expansion https://gov-pritzker-newsroom.prezly.com/governor-pritzker-announces-major-abbvie-manufacturing-expansion
- AbbVie Illinois manufacturing impact fact sheet https://www.abbvie.com/content/dam/abbvie-com2/pdfs/manufacture/abbvie-illinois-impact-fact-sheet.pdf
Cite this project
American Factory Tracker. "North Chicago Two-API-Facility Expansion — AbbVie, North Chicago, IL." https://americanfactorytracker.com/projects/abbvie-north-chicago-two-api-facilities. Accessed November 4, 2026.
Please also cite the original sources listed above for underlying figures.